TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
KLIC

Kulicke and Soffa Industries Inc

Technology · Semiconductor Equipment & Materials · listed since 1990

81.90$ +3.0% vs. previous close Closing price · As of: Sep 17, 2026
🔔 Watch stock
Add to watchlist

Assessment

Our Rating

A journalistic assessment by our editorial team at the time of the deep dive — it rates the company, not the entry point. Not investment advice and not a solicitation to buy or sell.

Open questions

The business works in principle, but one material question is open. As long as it stays open, our findings do not carry a quality verdict.

Why this colour

Whoever buys today is betting that the cycle upswing carries at least into fiscal year 2027 and that neither export controls nor the three top customers interfere — and pays 39 times an estimated, not-yet-earned profit for it. Whoever waits may miss further momentum percent, but receives fresh evidence at every quarterly date — the next is scheduled for August 5, 2026: do bookings and ball bonding growth stay double-digit, does gross margin hold the 45 percent zone, and does the China concentration ease? The decision is yours.

What the thesis turns on

Assessment: Opportunities & Risks

Kulicke & Soffa delivers the rare combination of a genuine, core-business-driven cycle turn (quarterly revenue up 49.8 percent, bookings up 74 percent) and a fortress balance sheet with almost half a billion dollars of net cash. Against that stand a price that pre-pays the continuation at 39 times estimated earnings, more than half of revenue with customers headquartered in China, three names as the load-bearing wall of the growth, an open CEO succession — and the certainty, documented in the company’s own annual report, that every aggressive customer investment phase so far has been followed by a phase of excess supply. Not investment advice.

Cycle turn & order intake

Revenue up 49.8 percent to $242.6 million in the second quarter of fiscal year 2026, ball bonding up 141.7 percent, memory revenue up elevenfold; fiscal 2025 bookings up 74 percent, backlog up 65 percent (10-Q as of 04/04/2026, 10-K FY 2025) — the turn comes from the core business.

Balance sheet & capital returns

$487.9 million in cash and investments against zero bank debt, a 72 percent equity ratio, Altman Z around 14; a $0.205 quarterly dividend and a $300 million buyback frame — though the buyback machine effectively stopped in the rally quarter ($0.1 million).

China & customer concentration

54.6 percent of quarterly revenue from customers headquartered in China, three customers at roughly 39 percent of first-half revenue, Huatian at 29.6 percent of receivables — squarely within the reach of U.S./China export-control policy (10-Q as of 04/04/2026; 10-K FY 2025, Item 1A).

Cyclicality & earnings history

Minus 57 percent of revenue from peak (FY 2021) to trough (FY 2025), fiscal 2025 net income of $213,000 shaped by one-offs in both directions (the $86.2 million walk-away payment, $87.5 million EA wind-down); an EPS rating of 6 out of 99 — the earnings base beneath the rally is young and thin.

Leadership & governance

CEO retirement effective December 1, 2025; since then CFO Lester Wong has led in a dual role as interim CEO, with the successor search open (10-K FY 2025, Note 18); plus an SEC comment letter of March 2026 about explanation gaps in the numbers work — routine, but no tailwind.

Valuation & technicals

31 hits in the momentum run (as of July 17, 2026), a stage-2 trend, relative strength of 97, about 3 percent below the all-time high — against a forward P/E around 39 (FY 2026 estimates) and a P/S around 9 (data as of July 8, 2026): the market pays for the upswing’s continuation in advance.

Worth Noting

KLIC reached the research list via the momentum/stage-2 run of our in-house stock scanner on July 17, 2026 (31 hits, including Stan Weinstein stage 2, RS leader ≥90, the Minervini trend template and pros 80 percent) — not via news flow or forum hype.

Scanner metrics (P/E, P/S, EPS rating, Piotroski, Altman Z) are computed on trailing twelve-month figures; they contain the one-off effects of the restructuring years (Project W reimbursement, EA wind-down) — and, by nature, not a possible further cycle push.

Price and valuation figures dated July 8, 2026 (about $131.50, roughly $6.9 billion market value); analyses are evergreen, daily prices are not a buy argument. The fiscal year ends in early October — all quarterly references carry the fiscal-year offset.

Read the Full Deep Dive Kulicke & Soffa Stock: A $6.9 Billion Valuation, $213,000 in Annual Profit — and a Chip Cycle Just Catching Fire Wire-bonder specialist Kulicke & Soffa lights up 31 filters in our in-house stock scanner (momentum run as of July 17, 2026) — a Stan Weinstein stage-2 uptrend, relative strength of 97, almost a four-bagger in twelve months (data as of July 8, 2026). We read the annual reports (10-K) for fiscal years 2023 through 2025 and the quarterly reports (10-Q) through April 4, 2026: a revenue mountain that ran from $1.5 billion down to $654 million, a comeback quarter at plus 49.8 percent, an $86 million walk-away payment from an unnamed mega-customer, three buried business lines, a CFO who doubles as interim CEO — and 54.6 percent of revenue from customers headquartered in China. Not investment advice — just the math on what a flawless uptrend costs when a cyclical has to deliver it. Read the analysis →

Stock Watch

This analysis is as of August 26, 2026. Stock Watch will tell you what's changed at KLIC since then.

Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.

Price history

Chart

Interactive price chart (TradingView).

52-week range: 35.30 $ to 133.80 $ · Last price: 81.90 $ (As of: September 17, 2026)

Key figures

Key figures at a glance

Every figure we hold for this stock, grouped by topic. The question mark next to a label explains what the number means.

Basics

Market Cap ?The value of the entire company on the market: share price times total shares outstanding. 4.3$B
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 52m
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 96.6%
Beta ?Volatility versus the overall market: 1 = moves like the market, 2 = twice as much, under 1 = calmer than the market. 1.6

Performance

Perf. 1M ?Price performance over the last month. 23.50%
Perf. 3M ?Price performance over the last 3 months. 100.00%
Perf. 6M ?Price performance over the last 6 months. 179.30%
YTD Performance (%) ?Price performance since the start of the year (Year to Date). 180.30%
52-Week-High Distance ?How far the price sits below its highest point over the last 52 weeks. 0% means the stock is at its year high. -1.4%
Perf. 1Y ?Price performance over the last 12 months. 101.74%
Perf. 3Y ?Price performance over the last 3 years. 82.03%
Perf. 5Y ?Price performance over the last 5 years. 31.42%
Perf. 10Y ?Price performance over the last 10 years. 668.00%
Perf. Since Inception ?Price performance since the first available trading day (02/21/1973) — with a complete history, that is since the IPO. 28,980.58%

Technical Indicators

MA 38 Days ?Moving average of the last 38 trading days: the smoothed price path. A price above it signals short-term strength. 86.80$
MA 50 Days ?Moving average of the last 50 trading days — the most widely watched medium-term trend line. 91.30$
MA 200 Days ?Moving average of the last 200 trading days — the dividing line between a long-term uptrend and downtrend. 80.70$
RSI (14) ?Relative Strength Index over 14 days, scale 0 to 100: above 70 counts as overbought, below 30 as oversold. A hint on timing, not a verdict on the company. 44.6
Volatility 30 Days ?Price swings over the last 30 trading days, annualized. The higher the value, the more the price fluctuates. 58.3%
Volatility 250 Days ?Price swings over the last 250 trading days (roughly one market year), annualized. 57.2%

Calculated from the price history · as of 09/18/2026

Valuation

P/E ?Price-to-earnings ratio: how many years of profit does the stock cost? The lower, the cheaper the valuation. No earnings means no P/E. 75.2
Forward P/E ?P/E based on expected earnings for the next 12 months instead of past earnings — analysts' bet on the future. 11.7
PEG ?P/E divided by expected earnings growth: puts valuation in relation to growth. Around 1 is considered fair, well above that is pricey. 2.4
P/B ?Price-to-book ratio: market value relative to book equity. 5.0
P/S ?Price-to-sales ratio: market value divided by annual sales. Important for companies that aren't (yet) profitable. 4.5
EV/EBITDA ?Enterprise value including debt (EV) relative to operating profit before depreciation and amortization (EBITDA) — more comparable than P/E because debt counts too. Extreme values arise when EBITDA is near zero. 22.7
Price/FCF ?Market value divided by free cash flow: how many years of freely available cash does the stock cost? More honest than P/E because cash flow is harder to dress up. 107.4

Profitability

Gross Margin ?Gross margin: what's left of sales after only direct production costs are deducted — the product's pricing power. 52.6%
EBIT Margin ?EBIT margin: operating profit as a percentage of sales — the earning power of the core business before interest and taxes. 15.9%
Net Margin ?Net margin: what's left of sales as profit after ALL costs, interest, and taxes. 12.2%
Return on Equity ?Return on equity: how much profit does the company generate per year on shareholders' equity? 6.4%
Return on Assets ?Return on assets: how much profit the company generates from its total assets (equity and debt combined). 9.0%

Balance Sheet & Safety

Equity Ratio ?Equity ratio: equity as a share of total assets. The higher, the more resilient the balance sheet. 72.3%
Debt/Equity ?Leverage ratio: financial debt divided by equity. Under 1 is generally seen as solid; negative values mean negative equity. 0.05
Altman Z″ ?Edward Altman's bankruptcy early-warning score. We use the Z″ variant, built from four balance-sheet ratios — it is designed for service companies and non-manufacturers and uses book value instead of market value. On that scale: below 1.1 = danger zone, 2.6 and up = safe zone, in between a grey area. Because the classic Altman Z is calculated differently, the two numbers are not directly comparable. The formula does not fit banks, insurers, or real-estate stocks. fortress balance sheet 13.92
Piotroski ?Balance-sheet health check by Joseph Piotroski: 9 yes/no criteria on profit, cash flow, leverage, and efficiency. 7+ is very solid, under 3 is a red flag. 6 out of 9

Growth

Sales Growth Last Quarter ?Sales growth in the most recently reported quarter versus the same quarter a year ago (YoY). 49.80%
EPS Growth Last Quarter ?Growth in earnings per share in the most recently reported quarter versus the same quarter a year ago (YoY). -78.80%
Sales Growth (Year) ?Sales growth in the last fiscal year versus the year before. -7.38%
Forward Sales Growth ?Sales growth analysts expect over the next 12 months — an estimate, not a guarantee. 17.57%
Forward EPS Growth ?Earnings-per-share growth analysts expect over the next 12 months — an estimate, not a guarantee. 26.10%

Dividend

Dividend Yield ?Annual dividend divided by the current price: what percentage of your investment comes back as a payout each year. 1.04%
Dividend Per Share (TTM) ?Sum of dividends paid per share over the last 12 months. 0.82$
Payout Ratio ?Share of profit paid out as dividends. Over 100% means the company is paying out more than it earns — not sustainable long-term. 31.5%
Years Without a Cut ?How many years in a row the dividend hasn't been cut — a measure of reliability. 7Years
Increase Streak ?How many years in a row the dividend has been raised — the gold standard for dividend payers. 7Years

Quality & Screener

Stage ?Weinstein phases 1 through 4: 1 = basing, 2 = uptrend (the only buy phase), 3 = topping, 4 = downtrend. Measured against the 30-week line. 2
RS Rating ?Relative strength from 1 to 99: an RS of 95 means the stock has outperformed 95% of all stocks. Top 10% 97
EPS Rating ?Earnings growth rating from 1 to 99 versus all stocks — high values mean above-average earnings growth. 6
Fundamental Rating ?Our own Fundamental Rating: 0 to 100 points with an A+ to F grade. 50 points is the average across the universe, 100 the best possible score. It scores growth, earnings surprises, analyst estimates, margins, cash flow, and balance-sheet safety — every stock percentile-ranked against all others. Grades: A+ from 95, A from 75, B from 55, C from 45, D from 25, E from 5, F below. A (77 out of 100)

Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.

Comparison

Industry comparison

The stock alongside the largest companies in the same group. The median row is the middle value of the companies shown above — not of the whole industry.

Industry: Semiconductor Equipment & Materials

Industry comparison
Company Market cap ($B) P/E EV/EBITDA Gross Margin % EBIT Margin % Sales Growth (Year) % Perf. 1Y %
Kulicke and Soffa Industries Inc KLIC 4.3 75.2 22.7 52.6 15.9 -7.4 101.7
Lam Research Corp LRCX 371.4 47.0 41.9 50.5 35.0 23.7 122.2
Applied Materials Inc AMAT 331.4 36.5 31.3 49.4 31.9 4.4 135.6
KLA Corporation KLAC 220.8 46.0 37.8 61.3 41.2 23.9 71.6
Teradyne Inc TER 57.6 59.4 34.3 59.2 37.6 13.1 209.5
Qnity Electronics, Inc Q 24.5 47.5 20.3 46.2 22.8 9.7 20.8
Entegris Inc ENTG 22.4 69.9 25.9 45.6 18.0 -1.4 41.1
Onto Innovation Inc ONTO 13.7 109.7 49.6 55.5 16.8 1.8 115.5
Amkor Technology Inc AMKR 11.9 23.7 8.5 15.5 6.0 6.2 81.4
Median of companies shown 24.5 47.5 31.3 50.5 22.8 6.2 101.7

Based on the most recently reported figures. Only stocks from the same trading venue are lined up, so the market caps are counted in one currency. Compare in a chart →

Fiscal years

Annual Figures

Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.

Revenue, operating income and net income per fiscal year $M

Revenue Operating income Net income

2016 · Revenue: 627 $M 2016 · Operating income: 54 $M 2016 · Net income: 48 $M 2017 · Revenue: 809 $M 2017 · Operating income: 113 $M 2017 · Net income: 126 $M 2018 · Revenue: 889 $M 2018 · Operating income: 167 $M 2018 · Net income: 57 $M 2019 · Revenue: 540 $M 2019 · Operating income: 22 $M 2019 · Net income: 12 $M 2020 · Revenue: 623 $M 2020 · Operating income: 59 $M 2020 · Net income: 52 $M 2021 · Revenue: 1,518 $M 2021 · Operating income: 412 $M 2021 · Net income: 367 $M 2022 · Revenue: 1,504 $M 2022 · Operating income: 470 $M 2022 · Net income: 434 $M 2023 · Revenue: 742 $M 2023 · Operating income: 39 $M 2023 · Net income: 57 $M 2024 · Revenue: 706 $M 2024 · Operating income: -93 $M 2024 · Net income: -69 $M 2025 · Revenue: 654 $M 2025 · Operating income: -3 $M 2025 · Net income: 0 $M
2016201720182019202020212022202320242025
Annual Figures
Fiscal Year Revenue ($M) EBIT ($M) Net Income ($M) EPS ($) Operating Cash Flow ($M) Equity ($M) Total Assets ($M)
2016 627 54 48 0.68 68 807 982
2017 809 113 126 1.75 136 913 1,171
2018 889 167 57 0.80 124 880 1,186
2019 540 22 12 0.18 66 769 1,080
2020 623 59 52 0.83 94 758 1,055
2021 1,518 412 367 5.78 300 1,095 1,602
2022 1,504 470 434 7.09 390 1,195 1,589
2023 742 39 57 0.99 173 1,175 1,500
2024 706 -93 -69 -1.24 31 944 1,240
2025 654 -3 0 0.00 114 821 1,104

Quarters

Quarterly Figures

Each bar is one quarter, the last one is the most recent. Use the switch to step through the individual figures.

Revenue & Profit

Cash Flow

Balance Sheet

Margins

Per Share

Click the chart or tab into it, then use ← and → to step through the periods.

None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.

These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.

The figures could not be loaded right now.

Sales Per Quarter ($M)
2024: Q4 · 166.1 $M Q4 2025: Q1 · 162.0 $M Q1 2025: Q2 · 148.4 $M Q2 2025: Q3 · 177.6 $M Q3 2025: Q4 · 199.6 $M Q4 2026: Q1 · 242.6 $M Q1 2026: Q2 · 330.4 $M Q2

Source: fundamental data

Quarterly Figures
Quarter EPS (Earnings Per Share) EPS YoY (%) Sales ($M) Sales YoY (%) Net Margin (%) OCF ($M) FCF ($M)
2024: Q4 1.51 824.10 166 -3.00 49.10 19 9
2025: Q1 -1.59 – 162 -5.90 -52.20 80 78
2025: Q2 -0.06 -128.40 148 -18.30 -2.20 7 5
2025: Q3 0.12 -44.90 178 -2.10 3.60 7 4
2025: Q4 0.32 -78.80 200 20.20 8.40 -9 -12
2026: Q1 0.66 – 243 49.80 14.50 10 6
2026: Q2 1.07 1,883.30 330 122.60 17.40 45 41

What Do These Terms Mean?

EPS (Earnings Per Share):
Quarterly profit divided by the total share count — how much of the profit works out to a single share.
YoY (Year over Year):
Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
Sales:
All revenue for the quarter, before any costs are deducted — the top line of the income statement.
Net Margin:
What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
OCF (Operating Cash Flow):
The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
FCF (Free Cash Flow):
Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.

Compare with other stocks →

Screening

Appears in These Scanners

This stock currently matches 34 of our scanner strategies — each hit links to the scanner.

Growth

Quality & Balance Sheet

Breakout & Setup

Momentum & Trend

Research

Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners

Outlook

Analysts & Price Target

Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.

Consensus Sell 1 = Strong buy … 5 = Strong sell
Analyst Ratings 5
Price Target (average) 106.67$
Distance to price 30.2% The price target sits 30.2% above the current price.

Distribution of Recommendations

Strong Buy 2
Buy 1
Hold 2
Sell 0
Strong Sell 0

Estimates by Fiscal Year

Estimates by Fiscal Year
Fiscal Year EPS Estimate ($) EPS Range ($) Revenue Estimate ($M) Expected Growth Analysts
09/30/2026 3.86 3.85 – 3.88 1,150 1,739.7% 3
09/30/2027 5.90 4.80 – 6.75 1,517 52.8% 3

Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.

Valuation

What is priced in?

Instead of guessing what the stock is worth, we turn the question around: what free cash flow growth has to happen for today’s market value to add up? The assumptions behind it can be moved.

Today’s market value implies roughly 30.9% growth in free cash flow per year over ten years (assumptions: discount rate 10.0%, terminal growth 2.5%).

What is priced in?
Free cash flow (last twelve months) $40.0M
Market cap $4.29B
Free cash flow in year ten $590.5M
Terminal value as a share of market value 72.6%

For comparison: over the past five years free cash flow grew by 3.1% per year.

It shows which assumption is built into today’s price, not whether that assumption will hold. Every assumption can be changed with the sliders; the figures move with them.

A simplified model calculation — not a forecast and not a recommendation.

AI classification

AI Rating

Neutral

Geprüft am 17.07.2026: In den ausgewerteten SEC-Berichten von Kulicke and Soffa Industries (CIK 56978; 4×10-Q bis zum 04.04.2026 plus 10-K für die Geschäftsjahre 2025 und 2024, Geschäftsjahresende Anfang Oktober) findet sich kein wesentlicher KI-Bezug im Sinne des Kriterienkatalogs. Befund: Die 10-Q zum 04.04.2026, 03.01.2026 und 28.06.2025 enthalten keinerlei KI-Treffer. Der 10-Q zum 29.03.2025 nennt „artificial intelligence“ nur regulatorisch — im Abschnitt zu US-Exportkontrollen wird das BIS-„Framework for AI Diffusion“ referiert („a set of additional export controls on advanced computing chips and certain closed artificial intelligence (‚AI‘) model weights“), also fremde Regeln, kein eigenes KI-Geschäft. Die 10-K für die Geschäftsjahre 2025 und 2024 erwähnen KI ausschließlich als Cyber-Boilerplate („artificial intelligence (‚AI‘) may be used to generate cyberattacks with greater scale and efficacy“ bzw. „threat actors may leverage other means and technologies, including artificial intelligence, to circumvent controls and avoid detection“) — generische Angriffsvektor-Floskeln, nach dem Kriterienkatalog kein Bedroht-Beleg. Eine KI-Umsatzquelle (verkauft) oder ein belegter operativer KI-Einsatz (nutzt) findet sich nirgends; dass die Endnachfrage nach Advanced-Packaging-/Memory-Equipment auch von KI-Rechenzentren getrieben sein dürfte, wird in den Filings nicht als eigener KI-Bezug ausgewiesen und bleibt damit außen vor. Nach dem Kriterienkatalog: „neutral“ (dokumentierter Negativ-Befund).

View the full file — quotes, sources, reviewed filings

Filings Reviewed: 10-Q 2026-05-07 · 10-Q 2026-02-05 · 10-Q 2025-08-06 · 10-Q 2025-05-07 · 10-K 2025-11-20 · 10-K 2024-11-14

Rated on July 17, 2026 · How the Rating Is Built

Growth

Growth Score

Ten checks against the annual reports — each one passed counts a point.

4 of 10 Weak growth
  • Revenue grows by more than 15% a year over three years -24.2%
  • More than 10% revenue growth is expected for the coming year 17.6%
  • Share count grows by less than 3% a year -4.6%
  • Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") 7.4%
  • Gross margin at 40% or higher and without meaningful erosion 42.5%
  • Goodwill from acquisitions does not grow faster than revenue 6.3%
  • Net debt below twice EBITDA 472 m net cash
  • Operating cash flow covers the profits of the last three years 330 m
  • Return on capital at 15% or higher, or up versus two years ago -0.4%
  • Insiders hold at least 10% or are net buyers 3.3%

A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail

Quality check

AAQS

4/10

The AAQS (AlleAktien Quality Score) checks 10 quality criteria on growth, profitability, and balance-sheet strength — per the methodology developed and published by AlleAktien, calculated by us from our own fundamental data. A stock counts as a quality stock from 9 out of 10 points. Where a company has a shorter listing history, we calculate over the fiscal years available (at least five).

  • Sales growth 10Y > 5% 0.5%
  • Exp. sales growth 3Y > 5% 52.3%
  • EBIT growth 10Y > 5% –
  • Exp. EBIT growth 3Y > 5% 3,741.6%
  • Net debt < 4x EBIT –
  • EBIT positive, 10Y straight 8
  • Max. EBIT decline < 50% 100.0%
  • Return on equity > 15% 0.0%
  • ROCE > 15% -0.4%
  • Expected return > 10% 3,828.0%

View stocks with the full AAQS score · Read the methodology at AlleAktien

Source: fundamental data

Insiders

Insider Transactions

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.

Insider Transactions
Date Person Role Type Shares Price Value
Sep 1, 2026 Wong Lester A CFO Other 6,038 0.00 –
Sep 1, 2026 Talluri Rajendra K CEO Other 89,697 0.00 –
Jul 6, 2026 Dignam Denise Director Other 407 0.00 –
Jul 6, 2026 Yeo Mui Sung Director Other 407 0.00 –
Jul 6, 2026 Kong Peter T M Director Other 407 0.00 –
Jul 6, 2026 Olson Jon A Director Other 407 0.00 –
Jul 6, 2026 Richardson David Jeffrey Director Other 407 0.00 –
Jul 6, 2026 Milzcik Gregory F Director Other 407 0.00 –

View all insider transactions →

The company

About the Company

Kulicke and Soffa Industries, Inc. entwirft, fertigt und verkauft Investitionsgüter und Verbrauchsmaterialien in China, den USA, Taiwan, Malaysia, Japan, den Philippinen, Korea, Hongkong und international.

Employees
2,551
Headquarters
Singapore, Singapore
Address
23A Serangoon North Avenue 5, 554369 Singapore, Singapore
Phone
65 6880 9600
Website
kns.com
IPO Date
03/26/1990
ISIN
US5012421013
Stock Split
2:1 on 08/01/2000
Stock Split
2:1 on 07/31/1995
Stock Split
2:1 on 05/23/1983

Management

Management
Name Title Birth Year
Lester A. Wong J.D. Executive VP of Finance & IT and CFO 1966
Robert Nestor Chylak Senior VP of Central Engineering & CTO 1959
Mun Pun Wong Senior Vice President of Global Sales & Supply Chain 1961
Fusen Ernie Chen Ph.D. Advisor 1959
Rajendra Talluri Ph.D. President, CEO & Director 1963
Joseph Elgindy Senior Director of Investor Relations & Strategic Planning –
Zi Yao Lim VP of Legal Affairs, General Counsel & Corporate Secretary 1988
Lisa Lim Vice President of Global Human Resources –
Meng Kwong Han Senior Vice President of Aftermarket Products & Services and Advanced Dispensing Solutions –

Executives per the latest required filings; titles kept in their original language. Source: fundamental data.

Filings

Company Filings (8-K)

An 8-K is the filing a US company must use to disclose material events immediately — takeovers, changes at the top, major contracts or payment troubles, for instance. The links open the original document at the US Securities and Exchange Commission (SEC).

  • 08/17/2026 KULICKE & SOFFA INDUSTRIES INC (KLIC): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Regulation FD Disclosure; Financial Statements and Exhibits SEC ↗
  • 08/05/2026 KULICKE & SOFFA INDUSTRIES INC (KLIC): Results of Operations and Financial Condition; Financial Statements and Exhibits SEC ↗

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?